top of page
Search
  • louisemlynch

Phytex announces Atropine Base and Atropine Sulfate available for supply

Updated: Jan 20, 2022

Phytex is pleased to announce Atropine Base and Atropine Sulfate are now available for supply. Phytex manufacturers these products from Australian sourced natural materials.

Atropa Belladonna

What is Atropine?

Atropine is a muscarinic antagonist used to treat poisoning by muscarinic agents, including organophosphates and other drugs. An alkaloid, originally from Atropa belladonna, but also found in other plants (Duboisia, Datura), mainly solanaceae.


Download the spec sheets:

Atropine Base EP USP Spec Sheet - FINAL
.pdf
Download PDF • 216KB

Atropine Sulfate USP Spec Sheet - FINAL
.pdf
Download PDF • 138KB

Extraction and isolation expertise

Phytex has a proven track record in supplying Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry to support research and development in formulation, for both clinical trials and commercial needs.


Phytex has the expertise and experience to deliver quality APIs in small gram batches, as well as the flexibility and capacity to scale up to commercial kilo quantities. The team understands the importance of drug continuity for key ingredients and are proud of its 40+ year history of zero product recalls.


Regulatory credentials

Phytex maintains the highest quality standards, manufacturing in strict accordance with cGMP and ICH Quality Guidelines - ICH Q7 - as well as 21 CFR part 210 and 211.


Phytex holds current regulatory licensing with the Australian Therapeutic Goods Administration as well as the U.S. Food and Drug Administration, in association with New Drug Applications and Abbreviated New Drug Applications with global pharmaceutical companies.


For Atropine Base and Atropine Sulfate enquiries, contact Phytex or one of our global agents:


Phytex

+61 (2) 9533 1324


TBL Pharma

Mitch Denny


Ethan InPharmaVit, Inc

Luzelena Munoz


To keep up to date with Phytex news, subscribe to our newsletter or follow us on LinkedIn.





142 views0 comments

コメント


bottom of page